• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [21726 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2012     Technology Assessment at SickKids (TASK) The use of biologic response modifiers in polyarticularcourse juvenile idiopathic arthritis - a systematic review update
2009     Technology Assessment at SickKids (TASK) Systematic review on orchidopexy for the Canadian Paediatric Surgical Wait Times project
2010     Technology Assessment at SickKids (TASK) Health technology assessment of thiopurine methyltransferase testing for guiding 6-mercaptopurine doses in pediatric patients with acute lymphoblastic leukemia
2010     Technology Assessment at SickKids (TASK) The use of biologic response modifiers in polyarticular-course juvenile idiopathic arthritis
2015     Technology Assessment at SickKids (TASK) Systematic review of the cost-effectiveness of influenza immunization programs: a Canadian perspective
2016     Technology Assessment at SickKids (TASK) Will the growth spurt continue? Trends in child health. Economic evaluation: 1980 to 2013
2016     Technology Assessment at SickKids (TASK) A microcosting and cost-consequence analysis of genomic testing strategies in autism spectrum disorder
2014     Technology Assessment at SickKids (TASK) The cost-effectiveness of clinic-based chloral hydrate sedation versus general anaesthesia for paediatric ophthalmological procedures
2013     Technology Assessment at SickKids (TASK) Thiopurine dosing using thiopurine methyltransferase status: a systematic review of clinical guidance
2019     Technology Assessment at SickKids (TASK) A microcosting and cost-consequence analysis of genomic testing strategies (including trios) in autism spectrum disorder: an update
2019     Technology Assessment at SickKids (TASK) The economic evaluation of early intervention with anti-tumor necrosis factor-α treatments in pediatric Crohn's disease
2019     Technology Assessment at SickKids (TASK) A cost-utility analysis of biosimilar infliximab compared to reference infliximab in adult switch patients with Crohn’s disease: a Canadian analysis
2015     Technology Assessment at SickKids (TASK) A cost-effectiveness analysis of maternal genotyping to guide treatment for postpartum pain and avert infant adverse events
2012     Technology Assessment at SickKids (TASK) The use of biologic response modifiers in polyarticular-course juvenile idiopathic arthritis
2008     Technology Assessment at SickKids (TASK) Caspofungin in the empiric treatment of febrile neutropenia in paediatric patients: A comparison with conventional and liposomal amphotericin B
2008     Technology Assessment Unit of the McGill University Health Centre (MUHC) Comparison of coblation tonsillectomy and electrocautery tonsillectomy in pediatric patients
2009     Technology Assessment Unit of the McGill University Health Centre (MUHC) Opportunity costs associated with technology expansion in the MUHC
2009     Technology Assessment Unit of the McGill University Health Centre (MUHC) The Impella percutaneous ventricular assist device
2009     Technology Assessment Unit of the McGill University Health Centre (MUHC) Subthalamic deep brain stimulation (DBS): clinical efficacy, safety and cost compared to medical therapy for the treatment of Parkinson's Disease
2009     Technology Assessment Unit of the McGill University Health Centre (MUHC) Percutaneous radiofrequency ablation for treatment of hepatocellular carcinoma
2009     Technology Assessment Unit of the McGill University Health Centre (MUHC) Clinical efficacy and cost of Allogenic Acellular Dermal Matrix (AADM) in implant-based breast reconstruction of post mastectomy cancer patients
2009     Technology Assessment Unit of the McGill University Health Centre (MUHC) Use of matrix coils in the treatment of cerebro-vascular aneurysms: an update
2009     Technology Assessment Unit of the McGill University Health Centre (MUHC) Efficacy and cost-effectiveness of Collatamp-G for infection prophylaxis in cardiac surgery
2009     Technology Assessment Unit of the McGill University Health Centre (MUHC) The use of probiotics in the prevention and treatment of clostridium difficile diarrhea: an update
2009     Technology Assessment Unit of the McGill University Health Centre (MUHC) Transcatheter Aortic Valve Implantation (TAVI) at the MUHC: a Health Technology Assessment
2009     Technology Assessment Unit of the McGill University Health Centre (MUHC) Radiofrequency ablation for treatment of Barrett's esophagus: A systematic review and cost analysis
2005     Technology Assessment Unit of the McGill University Health Centre (MUHC) Transplantation of allogeneic hematopoietic stem cells from unrelated donors in adult patients at the MUHC
2006     Technology Assessment Unit of the McGill University Health Centre (MUHC) Wait times at the MUHC. I: diagnostic imaging, joint replacement, cancer care, sight restoration, cardiac care
2009     Technology Assessment Unit of the McGill University Health Centre (MUHC) [The use of carmustine implants (Gliadel wafers) in patients with malignant glioma]
2006     Technology Assessment Unit of the McGill University Health Centre (MUHC) Wait times at the MUHC. 2: selected divisions of the departments of medicine and surgery. Supplement to report no 26 "Wait times at the MUHC 1"
2011     Technology Assessment Unit of the McGill University Health Centre (MUHC) X-ray versus gamma irradiation of blood components for prevention of transfusion-associated graft versus host disease: a brief report
2011     Technology Assessment Unit of the McGill University Health Centre (MUHC) The use of Lactobacillus probiotics in the prevention of antibiotic associated clostridium difficile diarrhea
2011     Technology Assessment Unit of the McGill University Health Centre (MUHC) Drug eluting stents. What should be the indications for their use at the MUHC?
2011     Technology Assessment Unit of the McGill University Health Centre (MUHC) Subglottic secretion drainage endotracheal tubes for prevention of ventilator-associated pneumonia
2010     Technology Assessment Unit of the McGill University Health Centre (MUHC) Efficacy and cost-effectiveness of a gentamicin-loaded collagen sponge as an adjuvant antibiotic prophylaxis for colorectal surgery
2012     Technology Assessment Unit of the McGill University Health Centre (MUHC) The clinical effectiveness and cost of a pneumococcal urine antigen immunochromatographic test (BinaxNOW Streptococcus pneumoniae) in the diagnosis of community acquire Streptococcus pneumoniae pneumonia in patients admitted to hospital
2010     Technology Assessment Unit of the McGill University Health Centre (MUHC) Efficacy, safety and cost of ultrafiltration for the management of acute decompensated heart failure
2010     Technology Assessment Unit of the McGill University Health Centre (MUHC) Argon beam coagulation in orthopaedic, urological and thoracic surgery at the MUHC: a brief report
2010     Technology Assessment Unit of the McGill University Health Centre (MUHC) Negative Pressure Wound Therapy (NPWT) (Update of Report 19)
2011     Technology Assessment Unit of the McGill University Health Centre (MUHC) Aortic valve bypass (apicoaortic conduit) in adult degenerative aortic stenosis
2013     Technology Assessment Unit of the McGill University Health Centre (MUHC) The effectiveness and safety of rituximab (anti-CD20) in neurologic autoimmune diseases
2013     Technology Assessment Unit of the McGill University Health Centre (MUHC) Transcatheter aortic valve implantation (TAVI) in patients with aortic stenosis. Update of Report No. 45
2013     Technology Assessment Unit of the McGill University Health Centre (MUHC) Surgical aortic valve replacement with the ATS Enable® sutureless aortic valve for aortic stenosis
2013     Technology Assessment Unit of the McGill University Health Centre (MUHC) Renal denervation for resistant hypertension
2002     Technology Assessment Unit of the McGill University Health Centre (MUHC) Should the McGill University Health Center replace the Jelco/Cathlon catheter by the ProtectIVPlus catheter for intravenous infusions?
2002     Technology Assessment Unit of the McGill University Health Centre (MUHC) Should the McGill University Health Centre initiate an antiviral treatment programme for patients with chronic hepatitis C?
2002     Technology Assessment Unit of the McGill University Health Centre (MUHC) Should the McGill University Health Center use mitoxantrone in the treatment of multiple sclerosis?
2002     Technology Assessment Unit of the McGill University Health Centre (MUHC) An evaluation of glycoprotein IIb/IIIa inhibitors during percutaneous coronary interventions at the MUHC: is there a difference between the drugs?
2003     Technology Assessment Unit of the McGill University Health Centre (MUHC) Should the MUHC use low-molecular-weight heparin in inpatient treatment of deep vein thrombosis with or without pulmonary embolism?
2003     Technology Assessment Unit of the McGill University Health Centre (MUHC) Should the MUHC approve the use of colorectal stents?
2003     Technology Assessment Unit of the McGill University Health Centre (MUHC) Should the MUHC approve the video capsule endoscopy system in the diagnosis of small bowel abnormalities?
2003     Technology Assessment Unit of the McGill University Health Centre (MUHC) Eprex and pure red cell aplasia: what should be MUHC policy for hemodialysis patients?
2004     Technology Assessment Unit of the McGill University Health Centre (MUHC) Use of carmustine implants (GLIADEL wafer) in patients with malignant glioma at The McGill University Health Centre
2004     Technology Assessment Unit of the McGill University Health Centre (MUHC) The use of biventricular pacemakers at the McGill University Health Centre
2004     Technology Assessment Unit of the McGill University Health Centre (MUHC) The gastric banding procedure: an evaluation
2006     Technology Assessment Unit of the McGill University Health Centre (MUHC) Should the McGill University Health Centre use safety devices to reduce needlestick injuries associated with intravascular infusions?
2004     Technology Assessment Unit of the McGill University Health Centre (MUHC) The use of matrix coils in the treatment of cerebro-vascular aneurysms
2006     Technology Assessment Unit of the McGill University Health Centre (MUHC) The use of mitoxantrone in the treatment of patients with multiple sclerosis: report update
2006     Technology Assessment Unit of the McGill University Health Centre (MUHC) Testing for HER2 positive breast cancer: a cost-effectiveness analysis
2007     Technology Assessment Unit of the McGill University Health Centre (MUHC) Wait times at the MUHC. No: 3 fracture management.
2008     Technology Assessment Unit of the McGill University Health Centre (MUHC) Wait times at the MUHC. No: 4 Diagnostic imaging revisited. Adult hospitals of the MUHC.
2008     Technology Assessment Unit of the McGill University Health Centre (MUHC) Adoption of liquid-based cytology: technological evaluation
2008     Technology Assessment Unit of the McGill University Health Centre (MUHC) Impact of TAU reports
2017     Technology Assessment Unit of the McGill University Health Centre (MUHC) Plerixafor as first-line choice for stem cell mobilization in non-Hodgkin's lymphoma and multiple myeloma patients
2012     Technology Assessment Unit of the McGill University Health Centre (MUHC) Drotrecogin alfa (Activated) in severe sepsis: a systematic review of observational studies (Update of Report 29)
2012     Technology Assessment Unit of the McGill University Health Centre (MUHC) Video capsule endoscopy for obscure GI bleeding and Crohn's disease (Update of Report 7)
2012     Technology Assessment Unit of the McGill University Health Centre (MUHC) 532 nm KTP laser for vocal fold surgery
2012     Technology Assessment Unit of the McGill University Health Centre (MUHC) Use of serum procalcitonin levels in treatment decisions for adult patients in the intensive care unit
2012     Technology Assessment Unit of the McGill University Health Centre (MUHC) The impact of reports of The Technology Assessment Unit of the McGill University Health Centre
2012     Technology Assessment Unit of the McGill University Health Centre (MUHC) Hyaluronic acid fat graft myringoplasty or Epidisk Tympanoplasty (ET)
2016     Technology Assessment Unit of the McGill University Health Centre (MUHC) Radiofrequency ablation for the treatment of Barrett's esophagus with high-grade and lowgrade dysplasia: an update
2015     Technology Assessment Unit of the McGill University Health Centre (MUHC) Single-dose intraoperative radiotherapy using Intrabeam® for early-stage breast cancer: an update
2016     Technology Assessment Unit of the McGill University Health Centre (MUHC) A mini-health technology assessment of Linear and Radial Endobronchial Ultrasound (EBUS) and Electromagnetic Navigation Bronchoscopy (ENB) in the diagnosis and staging of lung cancer in adults
2016     Technology Assessment Unit of the McGill University Health Centre (MUHC) Cardiac resynchronization therapy in heart failure
2016     Technology Assessment Unit of the McGill University Health Centre (MUHC) Use of biventricular pacing in atrioventricular heart block
2017     Technology Assessment Unit of the McGill University Health Centre (MUHC) Use of extracorporeal membrane oxygenation for cardiac life support in adult subjects
2011     Technology Assessment Unit of the McGill University Health Centre (MUHC) Fiducial markers for improving treatment margins in radiotherapy for prostate cancer
2011     Technology Assessment Unit of the McGill University Health Centre (MUHC) Use of the VerifyNow point of care test to detect nonresponsiveness to clopidogrel and aspirin
2010     Technology Assessment Unit of the McGill University Health Centre (MUHC) Efficacy and cost-effectiveness of a gentamicin-loaded collagen sponge as an adjuvant antibiotic prophylaxis for colorectal surgery
2010     Technology Assessment Unit of the McGill University Health Centre (MUHC) Efficacy, safety and cost of ultrafiltration for the management of acute decompensated heart failure.
2010     Technology Assessment Unit of the McGill University Health Centre (MUHC) Negative Pressure Wound Therapy (NPWT) Update to Report 19
2005     Technology Assessment Unit of the McGill University Health Centre (MUHC) The use of probiotics in the prevention and treatment of clostridium difficile diarrhea
2014     Technology Assessment Unit of the McGill University Health Centre (MUHC) Islet transplantation in patients with Type 1 Diabetes Mellitus
2014     Technology Assessment Unit of the McGill University Health Centre (MUHC) Excimer laser atherectomy for uncrossable coronary lesions and improperly deployed coronary stents
2003     Technology Assessment Unit of the McGill University Health Centre (MUHC) Use of the implantable cardiac defibrillator (ICD) at the McGill University Health Centre (MUHC)
2003     Technology Assessment Unit of the McGill University Health Centre (MUHC) The use of self-expanding metallic stents in the palliation of dysphagia in patients with malignant esophageal strictures
2003     Technology Assessment Unit of the McGill University Health Centre (MUHC) An evaluation of drug eluting (coated) stents for percutaneous coronary interventions: what should their role be at the McGill University Health Centre (MUHC)?
2007     Technology Assessment Unit of the McGill University Health Centre (MUHC) The use of image-free computer-assisted systems in total knee replacement surgeries
2012     Technology Assessment Unit of the McGill University Health Centre (MUHC) Evaluation of acellular dermal matrix for breast reconstruction: an update
2007     Technology Assessment Unit of the McGill University Health Centre (MUHC) Drotrecogin alfa (activated) in severe sepsis
2012     Technology Assessment Unit of the McGill University Health Centre (MUHC) The hybrid operating room. Should one be available for cardiovascular-thoracic procedures in the MUHC? A brief report
2012     Technology Assessment Unit of the McGill University Health Centre (MUHC) Single-dose intraoperative radiotherapy using Intrabeam® for early-stage breast cancer: a health technology assessment
2007     Technology Assessment Unit of the McGill University Health Centre (MUHC) Pulsatile machine perfusion compared to cold storage in kidney preservation
2005     Technology Assessment Unit of the McGill University Health Centre (MUHC) Vacuum-assisted wound closure therapy (V.A.C (R))
2005     Technology Assessment Unit of the McGill University Health Centre (MUHC) Intraoperative neurophysiological monitoring during spinal surgery
2005     Technology Assessment Unit of the McGill University Health Centre (MUHC) Cerebral microdialysis as a tool for neuromonitoring following traumatic brain injury
2005     Technology Assessment Unit of the McGill University Health Centre (MUHC) Botulinum toxin A for the treatment of refractory chronic anal fissures and internal anal sphincter achalasia in pediatric patients
2021     The Federal Joint Committee (G-BA) [Pharmaceutical Directive/Annex XII: Amikacin (Mycobacterium avium complex pulmonary infections)]
2021     The Federal Joint Committee (G-BA) [Pharmaceutical Directive/Annex XII: Atidarsagen autotemcel (metachromatic leukodystrophy with biallelic mutation in the ARSA gene)]
2021     The Federal Joint Committee (G-BA) [Pharmaceutical Directive/Annex XII: Autologous anti-CD19-transduced CD3+ cells (mantle cell lymphoma, pretreated patients)]